GLP-1 Protocol: Complete Cycling & Dosing Guide

Overview

GLP-1 receptor agonists are peptide hormones that activate the GLP-1 receptor, a G-protein coupled receptor responsible for glucose-dependent insulin secretion, appetite suppression, and metabolic regulation. Unlike traditional anabolic compounds, GLP-1 protocols are not structured around "blast and cruise" cycles but rather around dose escalation, maintenance phases, and strategic breaks to manage side effects and optimize outcomes.

The compound works through multiple mechanisms: binding to pancreatic beta cells to increase insulin secretion, suppressing glucagon release, slowing gastric emptying, and acting on hypothalamic centers to reduce appetite and caloric intake. These effects combine to produce reliable fat loss, improved metabolic markers, and secondary benefits across joint health, inflammation, and cardiovascular function.

Standard dosing ranges from 100–300 mcg administered via subcutaneous injection once or twice daily. Most users employ a 6–12 week escalation phase, followed by 12–16 weeks at target dose, with optional 4–8 week breaks to reset tolerance and manage gastrointestinal adaptation.

Standard Protocol

Typical Dosing Structure

Starting dose: 100 mcg once daily Escalation: Increase by 50–100 mcg every 3–7 days until reaching target Maintenance dose: 200–300 mcg once daily (or 100–150 mcg twice daily) Total cycle length: 16–28 weeks on, 4–8 weeks off

Phase 1: Initiation (Weeks 1–2)

Begin at 100 mcg once daily, typically in the morning 30 minutes before breakfast. This low starting dose minimizes nausea and allows your body to adapt to the receptor signaling. Many users experience mild appetite suppression and early satiety within 24–48 hours.

Daily protocol:

• Inject 100 mcg subcutaneously (abdomen, thigh, or upper arm)
• Consume a light breakfast 30 minutes post-injection
• Monitor for nausea; mild nausea is expected but should resolve within 2–4 hours

Phase 2: Escalation (Weeks 3–8)

Increase dose by 50 mcg every 3–5 days, moving from 100 mcg → 150 mcg → 200 mcg → 250 mcg → 300 mcg. Some users progress faster (every 3 days); others slow progression (every 7 days) if side effects escalate. The escalation phase builds tolerance while progressively increasing appetite suppression and fat mobilization.

Escalation schedule (conservative):

• Weeks 1–2: 100 mcg daily
• Weeks 3–4: 150 mcg daily
• Weeks 5–6: 200 mcg daily
• Weeks 7–8: 250–300 mcg daily

Escalation schedule (aggressive):

• Weeks 1–2: 100 mcg daily
• Week 3: 150 mcg daily
• Week 4: 200 mcg daily
• Week 5: 250 mcg daily
• Week 6: 300 mcg daily

Phase 3: Maintenance (Weeks 9–24)

Hold at your target dose (200–300 mcg once daily or split into 150 mcg twice daily). Most fat loss occurs during weeks 6–16 of the maintenance phase. Weekly weight loss averages 0.5–1.5 lbs, with accelerated loss in the first 4 weeks.

Maintenance protocol:

• Inject 200–300 mcg once daily, or 100–150 mcg twice daily (morning and evening)
• Maintain consistent injection timing
• Expect peak appetite suppression and steady fat mobilization
• Monitor weight weekly; adjust diet only if plateaued for 3+ weeks

Phase 4: Deload/Off-Cycle (Weeks 25–28+)

Take 4–8 weeks completely off to reset GLP-1R sensitivity, allow appetite to normalize, and assess long-term metabolic improvements. This break prevents downregulation of the receptor and reduces the risk of tolerance buildup. Many users report improved baseline appetite control and sustained weight loss after a deload.

Off-cycle protocol:

• Stop all injections immediately
• Expect appetite return within 3–7 days
• Maintain training and diet discipline; weight loss may slow but should not reverse significantly
• Use this period to assess whether body composition changes are sustainable without the compound
• Reintroduce at full dose (200–300 mcg) after 4–8 weeks if repeating the cycle

Goal-Specific Protocols

Protocol A: Fat Loss Maximization (Standard)

Cycle length: 20 weeks on, 6 weeks off Dosing: 100 mcg → 150 mcg → 200 mcg → 250 mcg → 300 mcg (escalation weeks 1–6), then 300 mcg daily for weeks 7–20 Frequency: Once daily, morning injection Expected outcome: 12–15% body weight reduction, predominantly from fat mass

This is the most straightforward protocol. Maintain a modest caloric deficit (300–500 kcal/day below maintenance) during weeks 6–20, when appetite suppression is maximal. The compound handles the appetite suppression; your job is calorie tracking and consistency.

Weekly milestones:

• Weeks 1–2: Mild nausea, appetite baseline
• Weeks 3–5: Growing appetite suppression, early weight loss (1–2 lbs)
• Weeks 6–10: Maximal appetite suppression, accelerated fat loss (1.5–2 lbs/week)
• Weeks 11–20: Steady fat loss, potential diet fatigue as calories remain low

Protocol B: Joint Health & Anti-Inflammation

Cycle length: 16 weeks on, 4 weeks off Dosing: 100 mcg → 150 mcg → 200 mcg → 250 mcg (escalation weeks 1–6), then 250 mcg daily for weeks 7–16 Frequency: Once daily Expected outcome: 25–35 point reduction in WOMAC pain scores, improved joint mobility

Lower dose suffices for anti-inflammatory benefits without maximizing fat loss. Target dose is 250 mcg daily, held for 10 weeks. This protocol is ideal for users prioritizing joint health and reducing systemic inflammation (CRP, TNF-α, IL-6 reduction).

Key nutritional additions:

• Collagen peptides: 10–15 g daily
• Omega-3 fatty acids: 2–3 g EPA/DHA daily
• Vitamin C: 500–1000 mg daily (supports collagen synthesis)
• Glucosamine + chondroitin: 1500/1200 mg daily

Protocol C: Metabolic & Hormonal Health (Conservative)

Cycle length: 12 weeks on, 8 weeks off Dosing: 100 mcg → 150 mcg → 200 mcg (escalation weeks 1–4), then 200 mcg daily for weeks 5–12 Frequency: 100 mcg twice daily (morning and evening) Expected outcome: 5–8% body weight loss, improved insulin sensitivity, normalized testosterone (in men), PCOS symptom improvement (in women)

This conservative protocol is designed for users who want metabolic benefits without aggressive fat loss. Splitting the dose into twice-daily 100 mcg injections smooths the effect and may reduce GI side effects. Ideal for those with existing muscle mass who want to preserve lean tissue.

Hormonal protocol add-ons (men):

• Maintain adequate protein intake: 1 g per lb of body weight
• Resistance training 4–5 days/week to preserve lean mass
• Caloric deficit no greater than 300 kcal/day
• Sleep: 7–9 hours nightly (supports testosterone recovery)

Protocol D: Longevity & Neuroprotection

Cycle length: Continuous (8–12 weeks on, 2–4 weeks minimal dose) Dosing: 100–150 mcg daily (lower maintenance dose) Frequency: Once daily Expected outcome: Reduced neuroinflammation, improved cognitive markers, cardiovascular protection

For users prioritizing anti-aging and longevity, a lower continuous dose (100–150 mcg daily) may offer neuroprotective benefits without the aggressive appetite suppression or lean mass loss associated with higher doses. This protocol requires less dietary discipline and minimal side effects.

Supportive compounds:

• NAD+ precursors (NMN or NR): 500–1000 mg daily
• Resveratrol: 150–500 mg daily
• Alpha-lipoic acid: 300–600 mg daily
• Regular cardiovascular exercise: 150+ minutes/week

How to Administer Step-by-Step

Subcutaneous Injection Technique

Equipment needed:

• GLP-1 peptide vial (typically 2–5 mg powder)
• Bacteriostatic water for reconstitution
• Insulin syringe (100 IU, 1 mL) or peptide syringe
• Alcohol swabs
• Sharps container

Reconstitution (First Use Only)

1. Calculate dilution: A 5 mg vial reconstituted with 5 mL bacteriostatic water yields 1000 mcg/mL (1 mcg per 0.001 mL). For easier dosing, use 2.5 mL water to yield 2000 mcg/mL (1 mcg per 0.0005 mL).
2. Sterilize vial top: Wipe the rubber septum with an alcohol swab; let dry 10 seconds.
3. Draw bacteriostatic water: Pull back the plunger to match the water volume you need (2.5–5 mL).
4. Inject water into vial: Inject water slowly into the vial; do not shake vigorously. Gentle rolling between palms for 30 seconds will dissolve the powder.
5. Allow 5–10 minutes: Let the reconstituted solution sit; cloudiness should clear. Solution is now ready for use.
6. Storage: Refrigerate reconstituted solution at 2–8°C. Shelf life is 30 days for bacteriostatic water reconstitution.

Daily Injection Protocol

1. Gather supplies: Vial, syringe, alcohol swab, and injection site.
2. Sterilize vial top: Wipe rubber septum with alcohol; let dry.
3. Draw dose: Pull plunger back to the appropriate mark for your dose (e.g., 0.3 mL for 300 mcg if using 1000 mcg/mL solution).
4. Insert needle: Push needle through the rubber septum at a 90-degree angle.
5. Inject air: Push the plunger slightly to inject an equal volume of air into the vial (prevents vacuum).
6. Withdraw peptide: Slowly pull the plunger back to draw your dose. Double-check the volume.
7. Remove needle: Carefully remove the needle from the vial.
8. Select injection site: Rotate between abdomen (ideal), thighs, and upper arms. Vary the site by 1–2 inches each injection to prevent lipohypertrophy.
9. Sterilize skin: Wipe the injection site with a fresh alcohol swab; let dry 10 seconds.
10. Inject: Pinch skin slightly, insert the needle at 45–90 degrees, and slowly depress the plunger. Aspiration (pulling back slightly before injection) is optional but reduces the risk of intravascular injection.
11. Remove needle: Withdraw the needle and apply gentle pressure with a clean gauze pad if bleeding occurs.
12. Dispose: Place used needles in a sharps container; never reuse needles.

Cycle Example: 20-Week Fat Loss Protocol (Week-by-Week)

What to Expect: Timeline of Effects

Days 1–3: Acute Response

• Mild to moderate nausea (most common at 100 mcg doses)
• Decreased appetite (subtle)
• Possible injection site redness or mild bruising
• No significant weight change

Days 4–7: Adaptation Phase

• Nausea resolves or significantly decreases
• Appetite suppression becomes noticeable
• Early satiety at meals
• Possible loose stools or constipation (usually transient)

Weeks 2–4: Dose Escalation Phase

• Growing appetite suppression with each dose increase
• Mild nausea returns briefly with each dose increase, then resolves
• Early weight loss (0.5–1 lb/week)
• Possible mild diarrhea; resolve by reducing fiber or taking psyllium husk

Weeks 5–10: Peak Effect Phase

• Maximal appetite suppression
• Nausea minimal or absent
• Accelerated weight loss (1.5–2 lbs/week)
• Improved energy and mental clarity
• Reduced cravings and food noise
• Decreased insulin levels and improved glucose control

Weeks 11–16: Plateau Phase

• Weight loss slows but continues (0.5–1 lb/week)
• Appetite suppression remains strong
• Possible psychological appetite (desire to eat despite satiety)
• Gastrointestinal side effects minimal
• Metabolic markers improve (lower triglycerides, better cholesterol, reduced inflammation)

Weeks 17–20: Late Maintenance Phase

• Continued steady fat loss
• Possible "diet fatigue" (psychological difficulty maintaining deficit)
• Appetite suppression may decline slightly if caloric intake increases
• Joint health and mobility improve (if this was a goal)

Post-Deload (Weeks 21–26)

• Appetite gradually normalizes over 3–7 days
• Weight stabilization; minor regain (2–5 lbs) is common as water/glycogen replenish
• Metabolic rate remains slightly elevated compared to baseline
• Long-term body composition changes persist if diet/training maintained

Common Protocol Mistakes

Mistake 1: Escalating Dose Too Quickly

Jumping 200+ mcg in a single increment or escalating every 1–2 days will trigger severe nausea and potential vomiting. Fix: Stick to 50–100 mcg increments every 3–7 days. Tolerance builds faster if you're patient.

Mistake 2: Maintaining Zero Caloric Deficit

GLP-1 suppresses appetite, but it doesn't create weight loss independently. Without a caloric deficit, weight loss will be minimal. Fix: Track calories loosely; aim for 300–500 kcal/day deficit. The appetite suppression makes this easy; don't waste it.

Mistake 3: Skipping Off-Cycle Periods

Continuous use without breaks leads to receptor downregulation (tolerance), requiring higher doses to achieve the same effect. Fix: Take 4–8 weeks completely off every 20–